控制的右心室压力过载可以通过促进双心室适应性缩来拯救左心室功能障碍
Matteo Ponzoni1, Azadeh Yeganeh2, Libo Zhang2
1Division of Cardiovascular Surgery, The Hospital for Sick Children, Toronto, Ontario, Canada.
JACC. Basic to translational science
|June 19, 2025
概括
肺动脉带 (PAB) 在心力衰竭的老鼠模型中改善了左心室 (LV) 功能. PAB促进了有益的LV重塑,减少了纤维化,改善了心脏细胞健康,为LV康复策略提供了洞察力.
科学领域:
- 心血管研究研究心血管研究
- 再生医学是一种再生医学.
- 心脏病的动物模型.
背景情况:
- 儿科扩张性心肌病经常涉及左心室 (LV) 功能障碍.
- 肺动脉带化 (PAB) 是用于LV功能障碍治疗的研究,但机制尚不清楚.
- 需要一个小型动物模型来研究PAB对LV康复的影响.
研究的目的:
- 建立和使用PAB治疗的小动物 LV 功能障碍模型.
- 为了记录由PAB引起的双心室血液动力学和组织水平的修改.
- 阐明了PAB介导的LV功能恢复背后的机制.
主要方法:
- 在Sprague-Dawley大鼠中通过LAD绑定创建了一个LV功能障碍模型.
- 在LAD + PAB组中,在受伤后一周应用了PAB.
- 在4周内利用每周的心声回声和末端组织病理学进行分析.
主要成果:
- 与LAD+PAB对照组相比,LAD+PAB大鼠显示LV射出分数有所改善,中枢输入量正常化.
- 组织学揭示了LV缩,心肌细胞直径增加和LAD+PAB大鼠中增强的新血管生成.
- PAB治疗减少了LV纤维化和纤维细胞衰老,保持了索兰的酸化.
结论:
- 在动物模型中,PAB诱导了积极的LV重塑和改善了缩-透缩功能.
- PAB刺激了双心室补偿性缩,这是LV恢复的潜在适应机制.
- 该模型展示了PAB在挽救残留LV功能和限制心脏纤维化/损伤方面的潜力.
相关概念视频
01:29Heart Failure II: Pathophysiology
59
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
59
01:29Cardiomyopathy V: Interprofessional Care
41
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
41
01:30Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
524
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
524
01:20Mitral Regurgitation I: Introduction
64
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
64
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
65
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
65